Simcere Pharmaceutical Group Statistics

Total Valuation

Simcere Pharmaceutical Group has a market cap or net worth of HKD 16.56 billion. The enterprise value is 14.54 billion.

Market Cap	16.56B
Enterprise Value	14.54B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	Jun 18, 2024

Share Statistics

Simcere Pharmaceutical Group has 2.51 billion shares outstanding. The number of shares has decreased by -1.94% in one year.

Shares Outstanding	2.51B
Shares Change (YoY)	-1.94%
Shares Change (QoQ)	-1.77%
Owned by Insiders (%)	5.05%
Owned by Institutions (%)	7.45%
Float	703.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	15.84
PS Ratio	2.50
PB Ratio	2.26
P/FCF Ratio	25.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.93, with an EV/FCF ratio of 22.10.

EV / Earnings	-12.28
EV / Sales	2.13
EV / EBITDA	10.93
EV / EBIT	14.34
EV / FCF	22.10

Financial Position

The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.17.

Current Ratio	2.10
Quick Ratio	1.82
Debt / Equity	0.17
Debt / EBITDA	0.96
Debt / FCF	1.93
Interest Coverage	23.46

Financial Efficiency

Return on equity (ROE) is -13.81% and return on invested capital (ROIC) is 6.39%.

Return on Equity (ROE)	-13.81%
Return on Assets (ROA)	4.79%
Return on Capital (ROIC)	6.39%
Revenue Per Employee	1.06M
Profits Per Employee	-184,723
Employee Count	7,027
Asset Turnover	0.52
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.76% in the last 52 weeks. The beta is 0.47, so Simcere Pharmaceutical Group's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	+0.76%
50-Day Moving Average	5.94
200-Day Moving Average	5.73
Relative Strength Index (RSI)	54.15
Average Volume (20 Days)	6,377,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Simcere Pharmaceutical Group had revenue of HKD 6.81 billion and -1.18 billion in losses. Loss per share was -0.46.

Revenue	6.81B
Gross Profit	5.25B
Operating Income	1.01B
Pretax Income	-1.17B
Net Income	-1.18B
EBITDA	1.23B
EBIT	1.01B
Loss Per Share	-0.46

Full Income Statement

Balance Sheet

The company has 3.28 billion in cash and 1.27 billion in debt, giving a net cash position of 2.01 billion or 0.80 per share.

Cash & Cash Equivalents	3.28B
Total Debt	1.27B
Net Cash	2.01B
Net Cash Per Share	0.80
Equity (Book Value)	7.42B
Book Value Per Share	2.93
Working Capital	3.61B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.18 billion and capital expenditures -519.18 million, giving a free cash flow of 658.09 million.

Operating Cash Flow	1.18B
Capital Expenditures	-519.18M
Free Cash Flow	658.09M
FCF Per Share	0.26

Full Cash Flow Statement

Margins

Gross margin is 77.05%, with operating and profit margins of 14.76% and -17.39%.

Gross Margin	77.05%
Operating Margin	14.76%
Pretax Margin	-17.19%
Profit Margin	-17.39%
EBITDA Margin	18.13%
EBIT Margin	14.76%
FCF Margin	9.66%

Dividends & Yields

This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 2.66%.

Dividend Per Share	0.18
Dividend Yield	2.66%
Dividend Growth (YoY)	-0.03%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	1.94%
Shareholder Yield	4.60%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Simcere Pharmaceutical Group has an Altman Z-Score of 3.45.

Altman Z-Score	3.45
Piotroski F-Score	n/a